Abiopharma

Dividend in the amount of 556.3464 agorot per share, record date: 19.8.26, payment 27.8.26

Q2/semi-annual report for 2026

General Announcement: Net Asset Value ("NAV") as of 11 August 2026

General Announcement: ALLOTMENT AND ISSUANCE OF SHARES PURSUANT TO WARRANT EXERCISE

Financial Statements and Related Announcement: Half Yearly Results

Events and transactions

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

Medi Lifestyle - Announcement

Silence Therapeutics - Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering

Borr Drilling Limited Announces Second Quarter 2026 Results

CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids

More than 160,000 Duke Energy customers in Ohio and Kentucky remain without power as second round of storms is expected

CLINUVEL’s injectable peptide platform